Benefitfocus (BNFT) Tops Q4 EPS by 4c, Offers Guidance

Benefitfocus (NASDAQ: BNFT) reported Q4 EPS of $0.14, $0.04 better than the analyst estimate of $0.10. Revenue for the quarter came in at $74.8 million versus the consensus estimate of $72.99 million.

GUIDANCE:

Benefitfocus sees Q1 2019 revenue of $66.5-68.5 million, versus the consensus of $71.51 million.

Benefitfocus sees FY2019 revenue of $301-309 million, versus the consensus of $297.51 million.

For earnings history and earnings-related data on Benefitfocus (BNFT) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Traws Pharma (TRAW) Tops Q2 EPS by 27c
• Citius Pharmaceuticals (CTXR) Misses Q3 EPS by 37c